Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotics Weight Gain”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Post-approval studies (Phase 4)Study completedNCT00806234
What this trial is testing

Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics

Who this might be right for
Psychotic Disorders
Johns Hopkins University 127
Post-approval studies (Phase 4)Looking for participantsNCT06740890
What this trial is testing

Exercise and Olanzapine-samidorphan

Who this might be right for
Schizophenia DisorderSchizoaffective DisorderBipolar Disorder I or II+1 more
New York State Psychiatric Institute 30
Not applicableStudy completedNCT00636896
What this trial is testing

Effects of Modafinil on Olanzapine Weight Gain

Who this might be right for
Weight Gain
Neuropsychiatric Research Institute, Fargo, North Dakota 50
Not applicableNot Yet RecruitingNCT07795554
What this trial is testing

The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain

Who this might be right for
Schizophrenia SpectrumSchizophreniaAntipsychotic Induced Weight Gain
Second Xiangya Hospital of Central South University 60
Post-approval studies (Phase 4)UnknownNCT00845936
What this trial is testing

Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics

Who this might be right for
Drug Induced Weight Gain
BeerYaakov Mental Health Center 30
Post-approval studies (Phase 4)Study completedNCT00290121
What this trial is testing

Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Université de Montréal 25
Not applicableStudy completedNCT00480168
What this trial is testing

A Prospective Study to Assess Metabolic Changes in Children and Adolescents Treated With Atypical Antipsychotics

Who this might be right for
Adverse Effects
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 50
Not applicableNot Yet RecruitingNCT07805980
What this trial is testing

A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia

Who this might be right for
SchizophreniaAntipsychotic Induced Weight Gain
Second Xiangya Hospital of Central South University 30
Not applicableStudy completedNCT01043250
What this trial is testing

Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

Who this might be right for
SchizophreniaSchizoaffective Disorder
Samsung Medical Center 81
Early research (Phase 1)Study completedNCT05857566
What this trial is testing

Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

Who this might be right for
Drug-induced Weight Gain
Response Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT04524403
What this trial is testing

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)
Corcept Therapeutics 150
Not applicableStudy completedNCT01222793
What this trial is testing

Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia

Who this might be right for
SchizophreniaObesity
National Institute on Drug Abuse (NIDA) 60
Post-approval studies (Phase 4)Study completedNCT00451399
What this trial is testing

Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain

Who this might be right for
Weight Gain
Central South University 128
Large-scale testing (Phase 3)Looking for participantsNCT07606014
What this trial is testing

No Guts No Glory Probiotics

Who this might be right for
Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine
University Medical Center Groningen 112
Post-approval studies (Phase 4)Study completedNCT00845988
What this trial is testing

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

Who this might be right for
Bipolar DisordersMetabolic Complication
Seoul National University Hospital 28
Testing effectiveness (Phase 2)Study completedNCT03818256
What this trial is testing

Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)
Corcept Therapeutics 71
Not applicableStudy completedNCT00344500
What this trial is testing

Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications

Who this might be right for
DiabetesObesityWeight Gain
VA Office of Research and Development 122
Post-approval studies (Phase 4)Not Yet RecruitingNCT07342764
What this trial is testing

Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)Antipsychotic-induced Weight Gain
Sultan Qaboos University 110
Testing effectiveness (Phase 2)Ended earlyNCT00617058
What this trial is testing

Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine

Who this might be right for
Weight Gain
University of North Carolina, Chapel Hill 1
Post-approval studies (Phase 4)Study completedNCT00391261
What this trial is testing

An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Cambridge Health Alliance 11
Next Page